HomeBlogBlogChronic Pain Treatment Denied by Insurance: Spinal Cord Stimulators and More
March 1, 2026
🛡️
ClaimBack Editorial Team
Insurance appeal specialists · Regulatory research team · How we verify accuracy

Chronic Pain Treatment Denied by Insurance: Spinal Cord Stimulators and More

Insurance denied spinal cord stimulator, intrathecal pump, nerve blocks, or opioid management for chronic pain? Learn how to appeal and what evidence to use.

Chronic Pain Treatment Denied by Insurance: Spinal Cord Stimulators and More

Chronic pain affects over 50 million Americans and is one of the leading causes of disability and reduced quality of life. Yet insurance denials for interventional pain management — spinal cord stimulators, intrathecal drug delivery systems, nerve blocks, and multimodal pain programs — are extremely common. These denials are frequently reversible with the right approach.

🛡️
Was your insurance claim denied?
Get a professional appeal letter in 3 minutes — citing real regulations for your country and insurer.
Start My Free Appeal →Free analysis · No login required

What Gets Denied in Chronic Pain Treatment

Spinal Cord Stimulation (SCS): Spinal cord stimulators are FDA-approved, Class III medical devices proven effective for complex regional pain syndrome, failed back surgery syndrome, and other refractory neuropathic pain conditions. Insurers deny SCS through several mechanisms:

  • Claiming step therapy requirements have not been met (requiring failure of conservative treatments, injections, and opioid therapy before approval)
  • Questioning whether the patient has completed a required psychological evaluation
  • Denying the trial period as separate from the permanent implant, or vice versa
  • Classifying the specific SCS technology (e.g., high-frequency 10kHz, closed-loop stimulation) as investigational

Intrathecal Drug Delivery Systems (Pain Pumps): Intrathecal pumps deliver medication directly to the spinal fluid and are used for refractory cancer pain and non-cancer chronic pain. Insurers often deny these as requiring prior failure of multiple systemic medication regimens, or classify specific medications (e.g., ziconotide) as experimental.

Interventional Nerve Blocks: Epidural steroid injections, facet joint injections, medial branch blocks, and radiofrequency ablation are commonly denied as not medically necessary, requiring additional diagnostic imaging, or applying frequency limits that conflict with clinical standards.

Multidisciplinary Pain Programs: Comprehensive pain rehabilitation programs — combining physical medicine, psychology, medication management, and occupational therapy — are strongly endorsed by pain medicine specialty societies as best practice for chronic pain. Insurers frequently deny these as "not medically necessary" or fail to cover them at adequate reimbursement levels.

Opioid Management: Patients with chronic pain who require ongoing opioid therapy face Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization barriers, quantity limits, and drug monitoring requirements. The CDC's 2022 updated Opioid Prescribing Guideline explicitly moves away from rigid prescribing thresholds, yet insurers still cite older, more restrictive guidance.

Key Clinical Evidence for Your Appeal

For SCS appeals:

  • The SENZA-RCT and ACCURATE trial demonstrate superiority of SCS versus continued medical management for failed back surgery syndrome and diabetic peripheral neuropathy
  • CMS covers SCS for FDA-approved indications; cite Medicare National Coverage Determination 160.7
  • The American Society of Interventional Pain Physicians (ASIPP) and the American Academy of Pain Medicine publish evidence-based guidelines supporting SCS

For nerve block denials:

Time-sensitive: appeal deadlines are real.
Most insurers require appeals within 30–180 days of denial. After that, you lose your right to contest. Start your free appeal now →
  • ASIPP Evidence-Based Practice Guidelines provide peer-reviewed support for interventional procedures
  • Document the diagnostic and therapeutic rationale for each procedure
  • Prior response to similar procedures strengthens the case for repeated interventions

For multidisciplinary pain program denials:

Fighting a denied claim?
ClaimBack generates a professional appeal letter in 3 minutes — citing real insurance regulations for your country. Get your free analysis →

  • The American Chronic Pain Association and Joint Commission pain management standards support comprehensive care
  • Functional outcome measures (PDI, BPI, SF-36) document impairment and can demonstrate the expected benefit of comprehensive treatment

Step Therapy and the "Fail First" Problem

Many insurer step-therapy protocols for interventional pain management require patients to "fail" conservative treatments before advanced interventions are approved. This approach is problematic because:

  1. It delays effective treatment, leading to progression of disability
  2. It may be clinically inappropriate — for some patients, earlier intervention is both safer and more cost-effective
  3. It may violate state step-therapy override laws if the prescribing physician documents clinical reasons that the preferred first-step treatment is contraindicated or clinically unsuitable

If your state has a step-therapy override statute (currently enacted in over 30 states), your physician can request an override by documenting clinical contraindications to the step-therapy requirement.

Building Your Pain Management Appeal

Compile the complete treatment record: Document every prior treatment attempt — physical therapy, medications, injections, behavioral interventions — with dates, providers, doses/frequency, duration, and outcomes. The more complete this history, the stronger the argument that the requested intervention is appropriate next-step care.

Get the interventional pain specialist involved: A board-certified pain management physician's medical necessity letter carries more weight than a primary care letter for these appeals. The specialist should specifically address the insurer's stated denial criteria.

Psychological evaluation documentation: Many SCS protocols require pre-implant psychological evaluation to assess for contraindications. If one has been completed, include it. If the insurer is using its absence as a denial reason, address the timeline for completing one.

Request peer-to-peer review: Interventional pain denials are frequently overturned at the peer-to-peer stage when a pain specialist speaks directly with the insurer's reviewing physician.

External Independent Review: Complete Guide" class="auto-link">External review: Independent external reviewers with pain medicine expertise are well-positioned to evaluate whether the insurer's criteria are consistent with current clinical standards.

Fight Back With ClaimBack

Chronic pain doesn't wait — and neither should your appeal. ClaimBack helps patients with chronic pain conditions build medically grounded appeals that address the specific barriers their insurers are using.

Start your chronic pain insurance appeal at ClaimBack


💰

How much did your insurer deny?

Enter your denied claim amount to see what you could recover.

$
📋
Get the free appeal checklist
The 12-point checklist that helped ~60% of appealed claims get overturned.
Free · No spam · Unsubscribe any time
40–83% of appeals win. Yours could too.

Your insurer is counting on you giving up.

Most people do. Less than 1% of denied claimants ever appeal — even though the majority who do win. ClaimBack was built by people who were denied, who fought back, and who refused to accept "no" from an insurer.

We give you the same appeal arguments that attorneys use — in 3 minutes, for free. Your denial deadline is ticking. Don't let it expire.

Free analysis · No credit card · Takes 3 minutes

More from ClaimBack

ClaimBack helps you fight denied insurance claims with appeal letters built on AI and data from thousands of real denials. Start your free analysis — it takes 3 minutes.